Figure 1From: Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]Trial profile. Patients who had a dose reduction following the protocol were included in all analyses.Back to article page